| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.963 | 0.002 | 0.963 | Hypolipemic | 0.945 0.002 DBMET02469 0.963 0.002 DBMET02472 0.951 0.002 DBMET02473 0.929 0.003 DBMET02475 0.853 0.003 DBMET02476 0.95 0.002 DBMET02478 0.894 0.003 DBMET02479 0.936 0.003 DBMET02470 0.931 0.003 DBMET02471 0.96 0.002 DBMET02474 | ||
| 0.864 | 0 | 0.864 | HMG CoA reductase inhibitor | 0.735 0.001 DBMET02469 0.864 0 DBMET02472 0.761 0.001 DBMET02473 0.555 0.001 DBMET02475 0.228 0.001 DBMET02476 0.829 0.001 DBMET02478 0.591 0.001 DBMET02479 0.692 0.001 DBMET02470 0.662 0.001 DBMET02471 0.794 0.001 DBMET02474 | ||
| 0.843 | 0.01 | 0.924 | Transcription factor NF kappa B inhibitor | 0.732 0.017 DBMET02469 0.843 0.01 DBMET02472 0.692 0.021 DBMET02473 0.924 0.004 DBMET02475 0.692 0.021 DBMET02476 0.811 0.012 DBMET02478 0.588 0.033 DBMET02479 0.699 0.02 DBMET02470 0.761 0.015 DBMET02471 0.708 0.019 DBMET02474 | DBMET02475 | |
| 0.823 | 0.002 | 0.823 | Insulin sensitizer | 0.502 0.004 DBMET02469 0.823 0.002 DBMET02472 0.407 0.006 DBMET02473 0.558 0.003 DBMET02475 0.473 0.004 DBMET02476 0.799 0.002 DBMET02478 0.469 0.004 DBMET02479 0.447 0.005 DBMET02470 0.417 0.005 DBMET02471 0.43 0.005 DBMET02474 | ||
| 0.806 | 0 | 0.806 | Cholesterol synthesis inhibitor | 0.746 0.001 DBMET02469 0.806 0 DBMET02472 0.654 0.001 DBMET02473 0.722 0.001 DBMET02475 0.523 0.002 DBMET02476 0.759 0.001 DBMET02478 0.474 0.003 DBMET02479 0.484 0.003 DBMET02470 0.678 0.001 DBMET02471 0.686 0.001 DBMET02474 | ||
| 0.66 | 0.005 | 0.831 | Apoptosis antagonist | 0.597 0.01 DBMET02469 0.66 0.005 DBMET02472 0.538 0.016 DBMET02473 0.668 0.005 DBMET02475 0.831 0.003 DBMET02476 0.673 0.005 DBMET02478 0.508 0.019 DBMET02479 0.419 0.033 DBMET02470 0.6 0.01 DBMET02471 0.549 0.015 DBMET02474 | DBMET02476 | |
| 0.652 | 0.005 | 0.829 | Angiogenesis stimulant | 0.453 0.015 DBMET02469 0.652 0.005 DBMET02472 0.566 0.008 DBMET02473 0.829 0.003 DBMET02475 0.472 0.014 DBMET02476 0.579 0.008 DBMET02478 0.39 0.023 DBMET02479 0.411 0.02 DBMET02470 0.407 0.02 DBMET02471 0.45 0.015 DBMET02474 | DBMET02475 | |
| 0.61 | 0.017 | 0.699 | Cholesterol antagonist | 0.505 0.032 DBMET02469 0.61 0.017 DBMET02472 0.263 0.116 DBMET02473 0.699 0.008 DBMET02475 0.536 0.027 DBMET02476 0.554 0.024 DBMET02478 0.557 0.024 DBMET02479 0.342 0.067 DBMET02470 0.433 0.043 DBMET02471 0.289 0.099 DBMET02474 | DBMET02475 | |
| 0.593 | 0.008 | 0.689 | Vasodilator, coronary | 0.452 0.023 DBMET02469 0.593 0.008 DBMET02472 0.305 0.083 DBMET02473 0.689 0.005 DBMET02475 0.513 0.014 DBMET02476 0.483 0.018 DBMET02478 0.313 0.077 DBMET02479 0.206 0.177 DBMET02470 0.413 0.031 DBMET02471 0.337 0.062 DBMET02474 | DBMET02475 | |
| 0.593 | 0.014 | 0.608 | Immunosuppressant | 0.49 0.036 DBMET02469 0.593 0.014 DBMET02472 0.588 0.015 DBMET02473 0.608 0.012 DBMET02475 0.572 0.017 DBMET02476 0.591 0.014 DBMET02478 0.51 0.03 DBMET02479 0.59 0.014 DBMET02470 0.582 0.015 DBMET02471 0.558 0.019 DBMET02474 | DBMET02475 | |
| 0.578 | 0.005 | 0.578 | P-glycoprotein inhibitor | 0.416 0.014 DBMET02469 0.578 0.005 DBMET02472 0.406 0.015 DBMET02473 0.481 0.009 DBMET02475 0.429 0.013 DBMET02476 0.511 0.008 DBMET02478 0.333 0.023 DBMET02479 0.379 0.018 DBMET02470 0.48 0.009 DBMET02471 0.453 0.011 DBMET02474 | ||
| 0.539 | 0.031 | 0.732 | Antibacterial | 0.494 0.042 DBMET02469 0.539 0.031 DBMET02472 0.593 0.02 DBMET02473 0.732 0.007 DBMET02475 0.635 0.015 DBMET02476 0.581 0.022 DBMET02478 0.423 0.067 DBMET02479 0.593 0.02 DBMET02470 0.546 0.029 DBMET02471 0.592 0.02 DBMET02474 | DBMET02475 | |
| 0.516 | 0.012 | 0.536 | Platelet antagonist | 0.434 0.021 DBMET02469 0.516 0.012 DBMET02472 0.414 0.024 DBMET02473 0.536 0.01 DBMET02475 0.386 0.03 DBMET02476 0.522 0.012 DBMET02478 0.41 0.025 DBMET02479 0.446 0.02 DBMET02470 0.438 0.021 DBMET02471 0.434 0.021 DBMET02474 | DBMET02475 | |
| 0.532 | 0.065 | 0.639 | Apoptosis agonist | 0.607 0.048 DBMET02469 0.532 0.065 DBMET02472 0.639 0.041 DBMET02473 0.634 0.042 DBMET02475 0.433 0.098 DBMET02476 0.483 0.08 DBMET02478 0.371 0.128 DBMET02479 0.603 0.048 DBMET02470 0.625 0.044 DBMET02471 0.524 0.067 DBMET02474 | DBMET02473 | |
| 0.521 | 0.079 | 0.71 | Antiinflammatory | 0.42 0.127 DBMET02469 0.521 0.079 DBMET02472 0.685 0.034 DBMET02473 0.71 0.029 DBMET02475 0.446 0.112 DBMET02476 0.495 0.09 DBMET02478 0.42 0.127 DBMET02470 0.451 0.11 DBMET02471 0.474 0.099 DBMET02474 | DBMET02475 | |
| 0.463 | 0.037 | 0.64 | Vasodilator, peripheral | 0.599 0.016 DBMET02469 0.463 0.037 DBMET02472 0.427 0.047 DBMET02473 0.428 0.047 DBMET02475 0.369 0.066 DBMET02478 0.64 0.012 DBMET02479 0.365 0.068 DBMET02470 0.494 0.029 DBMET02471 0.374 0.064 DBMET02474 | DBMET02479 | |
| 0.419 | 0.007 | 0.457 | NOS3 expression enhancer | 0.308 0.017 DBMET02469 0.419 0.007 DBMET02472 0.222 0.033 DBMET02473 0.457 0.006 DBMET02475 0.334 0.013 DBMET02476 0.427 0.007 DBMET02478 0.371 0.01 DBMET02479 0.177 0.052 DBMET02470 0.316 0.015 DBMET02471 0.324 0.014 DBMET02474 | DBMET02475 | |
| 0.434 | 0.041 | 0.75 | Antithrombotic | 0.394 0.051 DBMET02469 0.434 0.041 DBMET02472 0.284 0.1 DBMET02473 0.75 0.006 DBMET02475 0.242 0.132 DBMET02476 0.365 0.059 DBMET02478 0.439 0.04 DBMET02479 0.412 0.046 DBMET02470 0.303 0.086 DBMET02471 0.315 0.079 DBMET02474 | DBMET02475 | |
| 0.409 | 0.022 | 0.515 | Vasodilator | 0.365 0.029 DBMET02469 0.409 0.022 DBMET02472 0.341 0.036 DBMET02473 0.44 0.017 DBMET02475 0.515 0.011 DBMET02476 0.514 0.011 DBMET02478 0.304 0.047 DBMET02479 0.252 0.068 DBMET02470 0.349 0.033 DBMET02471 0.327 0.04 DBMET02474 | DBMET02476 | |
| 0.427 | 0.042 | 0.664 | Immunostimulant | 0.387 0.054 DBMET02469 0.427 0.042 DBMET02472 0.463 0.034 DBMET02473 0.664 0.01 DBMET02475 0.281 0.084 DBMET02476 0.432 0.041 DBMET02478 0.374 0.058 DBMET02479 0.448 0.037 DBMET02470 0.398 0.05 DBMET02471 0.412 0.046 DBMET02474 | DBMET02475 | |
| 0.439 | 0.071 | 0.66 | Cyclophilin D inhibitor | 0.386 0.099 DBMET02469 0.439 0.071 DBMET02472 0.47 0.06 DBMET02473 0.66 0.018 DBMET02475 0.485 0.055 DBMET02476 0.493 0.052 DBMET02478 0.385 0.099 DBMET02479 0.42 0.08 DBMET02471 0.367 0.11 DBMET02474 | DBMET02475 | |
| 0.394 | 0.026 | 0.483 | Nitric oxide antagonist | 0.389 0.027 DBMET02469 0.394 0.026 DBMET02472 0.48 0.017 DBMET02473 0.483 0.017 DBMET02475 0.378 0.028 DBMET02476 0.413 0.024 DBMET02478 0.271 0.046 DBMET02479 0.391 0.027 DBMET02470 0.406 0.025 DBMET02471 0.431 0.022 DBMET02474 | DBMET02475 | |
| 0.325 | 0.005 | 0.325 | ABCA1 expression enhancer | 0.247 0.006 DBMET02469 0.325 0.005 DBMET02472 0.144 0.019 DBMET02473 0.18 0.012 DBMET02475 0.188 0.011 DBMET02476 0.262 0.005 DBMET02478 0.193 0.01 DBMET02479 0.124 0.028 DBMET02470 0.191 0.01 DBMET02471 0.199 0.009 DBMET02474 | ||
| 0.338 | 0.021 | 0.488 | Hepatoprotectant | 0.341 0.02 DBMET02469 0.338 0.021 DBMET02472 0.444 0.01 DBMET02473 0.488 0.008 DBMET02475 0.262 0.04 DBMET02476 0.305 0.028 DBMET02478 0.259 0.041 DBMET02479 0.336 0.021 DBMET02470 0.324 0.024 DBMET02471 0.327 0.023 DBMET02474 | DBMET02475 | |
| 0.32 | 0.005 | 0.498 | AMP-activated protein kinase stimulant | 0.149 0.029 DBMET02469 0.32 0.005 DBMET02472 0.498 0.003 DBMET02475 0.111 0.057 DBMET02476 0.238 0.007 DBMET02478 0.134 0.039 DBMET02479 0.126 0.044 DBMET02471 0.158 0.023 DBMET02474 | DBMET02475 | |
| 0.351 | 0.038 | 0.57 | Hypoglycemic | 0.322 0.046 DBMET02469 0.351 0.038 DBMET02472 0.427 0.024 DBMET02473 0.57 0.01 DBMET02475 0.211 0.102 DBMET02476 0.291 0.056 DBMET02478 0.382 0.031 DBMET02479 0.232 0.088 DBMET02470 0.333 0.042 DBMET02471 0.327 0.044 DBMET02474 | DBMET02475 | |
| 0.347 | 0.047 | 0.53 | Antioxidant | 0.361 0.043 DBMET02469 0.347 0.047 DBMET02472 0.336 0.05 DBMET02473 0.53 0.017 DBMET02475 0.279 0.07 DBMET02476 0.299 0.062 DBMET02478 0.331 0.051 DBMET02479 0.288 0.066 DBMET02470 0.349 0.047 DBMET02471 0.354 0.045 DBMET02474 | DBMET02475 | |
| 0.335 | 0.05 | 0.361 | Sodium/bile acid cotransporter inhibitor | 0.354 0.037 DBMET02469 0.335 0.05 DBMET02472 0.326 0.057 DBMET02473 0.241 0.138 DBMET02475 0.244 0.134 DBMET02476 0.299 0.08 DBMET02478 0.361 0.033 DBMET02479 0.296 0.083 DBMET02470 0.346 0.043 DBMET02471 0.329 0.055 DBMET02474 | DBMET02479 | |
| 0.298 | 0.025 | 0.365 | Peptidyltransferase inhibitor | 0.172 0.142 DBMET02469 0.298 0.025 DBMET02472 0.255 0.047 DBMET02473 0.365 0.01 DBMET02475 0.318 0.019 DBMET02476 0.303 0.024 DBMET02478 0.217 0.079 DBMET02479 0.21 0.087 DBMET02471 0.253 0.048 DBMET02474 | DBMET02475 | |
| 0.258 | 0.007 | 0.258 | Microtubule formation inhibitor | 0.206 0.018 DBMET02469 0.258 0.007 DBMET02472 0.195 0.021 DBMET02473 0.252 0.008 DBMET02475 0.217 0.016 DBMET02476 0.232 0.013 DBMET02478 0.148 0.038 DBMET02479 0.225 0.015 DBMET02470 0.175 0.027 DBMET02471 0.229 0.014 DBMET02474 | ||
| 0.237 | 0.003 | 0.237 | Prostaglandin F2 alpha antagonist | 0.135 0.005 DBMET02469 0.237 0.003 DBMET02472 0.219 0.004 DBMET02473 0.143 0.005 DBMET02475 0.103 0.01 DBMET02476 0.214 0.004 DBMET02478 0.198 0.004 DBMET02479 0.132 0.005 DBMET02470 0.136 0.005 DBMET02471 0.211 0.004 DBMET02474 | ||
| 0.249 | 0.025 | 0.249 | Bone formation stimulant | 0.144 0.064 DBMET02469 0.249 0.025 DBMET02472 0.131 0.076 DBMET02473 0.166 0.048 DBMET02475 0.171 0.045 DBMET02476 0.224 0.03 DBMET02478 0.21 0.033 DBMET02479 0.124 0.082 DBMET02471 0.143 0.065 DBMET02474 | ||
| 0.24 | 0.015 | 0.381 | Antineoplastic antibiotic | 0.237 0.016 DBMET02469 0.24 0.015 DBMET02472 0.381 0.006 DBMET02473 0.311 0.009 DBMET02475 0.286 0.01 DBMET02476 0.284 0.011 DBMET02478 0.132 0.035 DBMET02479 0.337 0.008 DBMET02470 0.316 0.009 DBMET02471 0.229 0.017 DBMET02474 | DBMET02473 | |
| 0.292 | 0.072 | 0.528 | 5 Hydroxytryptamine release stimulant | 0.514 0.025 DBMET02469 0.292 0.072 DBMET02472 0.348 0.057 DBMET02473 0.359 0.054 DBMET02475 0.206 0.116 DBMET02478 0.528 0.023 DBMET02479 0.327 0.062 DBMET02470 0.43 0.04 DBMET02471 0.324 0.063 DBMET02474 | DBMET02479 | |
| 0.214 | 0.006 | 0.243 | Prostaglandin EP2 antagonist | 0.172 0.008 DBMET02469 0.214 0.006 DBMET02472 0.141 0.011 DBMET02473 0.153 0.009 DBMET02475 0.057 0.044 DBMET02476 0.201 0.006 DBMET02478 0.243 0.005 DBMET02479 0.088 0.023 DBMET02470 0.17 0.008 DBMET02471 0.207 0.006 DBMET02474 | DBMET02479 | |
| 0.288 | 0.082 | 0.384 | Interleukin 2 agonist | 0.334 0.053 DBMET02469 0.288 0.082 DBMET02472 0.285 0.085 DBMET02473 0.384 0.032 DBMET02475 0.258 0.11 DBMET02476 0.275 0.094 DBMET02478 0.319 0.061 DBMET02479 0.266 0.102 DBMET02470 0.323 0.059 DBMET02471 0.29 0.081 DBMET02474 | DBMET02475 | |
| 0.208 | 0.003 | 0.208 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.077 0.005 DBMET02469 0.208 0.003 DBMET02472 0.037 0.026 DBMET02475 0.048 0.013 DBMET02476 0.105 0.004 DBMET02478 0.043 0.017 DBMET02471 0.044 0.016 DBMET02474 | ||
| 0.202 | 0.002 | 0.202 | Squalene epoxidase inhibitor | 0.097 0.005 DBMET02469 0.202 0.002 DBMET02472 0.061 0.02 DBMET02473 0.1 0.005 DBMET02475 0.071 0.013 DBMET02476 0.125 0.004 DBMET02478 0.073 0.013 DBMET02479 0.048 0.038 DBMET02470 0.066 0.016 DBMET02471 0.082 0.009 DBMET02474 | ||
| 0.224 | 0.034 | 0.364 | Protein kinase stimulant | 0.283 0.019 DBMET02469 0.224 0.034 DBMET02472 0.164 0.059 DBMET02473 0.294 0.018 DBMET02475 0.172 0.054 DBMET02476 0.116 0.097 DBMET02478 0.247 0.027 DBMET02479 0.241 0.029 DBMET02470 0.364 0.011 DBMET02471 0.202 0.041 DBMET02474 | DBMET02471 | |
| 0.193 | 0.005 | 0.193 | Thioredoxin reductase inhibitor | 0.164 0.007 DBMET02469 0.193 0.005 DBMET02472 0.094 0.035 DBMET02473 0.155 0.009 DBMET02475 0.155 0.009 DBMET02476 0.191 0.005 DBMET02478 0.154 0.009 DBMET02479 0.111 0.021 DBMET02470 0.118 0.017 DBMET02471 0.131 0.013 DBMET02474 | ||
| 0.18 | 0.003 | 0.192 | Prostaglandin agonist | 0.093 0.005 DBMET02469 0.18 0.003 DBMET02472 0.06 0.008 DBMET02473 0.028 0.025 DBMET02475 0.036 0.016 DBMET02476 0.179 0.004 DBMET02478 0.135 0.004 DBMET02479 0.057 0.009 DBMET02470 0.132 0.004 DBMET02471 0.192 0.003 DBMET02474 | DBMET02474 | |
| 0.244 | 0.086 | 0.244 | Gastrin inhibitor | 0.244 0.086 DBMET02472 0.213 0.129 DBMET02476 0.191 0.162 DBMET02478 0.229 0.106 DBMET02479 | ||
| 0.144 | 0.003 | 0.144 | Integrin alphaLbeta2 antagonist | 0.039 0.004 DBMET02469 0.144 0.003 DBMET02472 0.015 0.007 DBMET02473 0.047 0.004 DBMET02475 0.064 0.004 DBMET02476 0.072 0.004 DBMET02478 0.014 0.008 DBMET02470 0.023 0.005 DBMET02471 0.029 0.004 DBMET02474 | ||
| 0.195 | 0.06 | 0.208 | Lipocortins synthesis antagonist | 0.208 0.052 DBMET02469 0.195 0.06 DBMET02472 0.147 0.109 DBMET02473 0.14 0.121 DBMET02475 0.157 0.095 DBMET02476 0.185 0.067 DBMET02478 0.176 0.074 DBMET02479 0.201 0.055 DBMET02471 0.192 0.061 DBMET02474 | DBMET02469 | |
| 0.177 | 0.052 | 0.273 | Interferon gamma antagonist | 0.223 0.034 DBMET02469 0.177 0.052 DBMET02472 0.211 0.037 DBMET02473 0.273 0.024 DBMET02475 0.14 0.092 DBMET02476 0.158 0.068 DBMET02478 0.255 0.028 DBMET02479 0.227 0.033 DBMET02470 0.252 0.028 DBMET02471 0.266 0.025 DBMET02474 | DBMET02475 | |
| 0.13 | 0.014 | 0.132 | ATPase (Vacuolar H+) inhibitor | 0.112 0.026 DBMET02469 0.13 0.014 DBMET02472 0.109 0.029 DBMET02473 0.124 0.017 DBMET02475 0.125 0.016 DBMET02476 0.13 0.014 DBMET02478 0.131 0.014 DBMET02479 0.116 0.022 DBMET02470 0.132 0.013 DBMET02471 0.11 0.028 DBMET02474 | DBMET02471 | |
| 0.138 | 0.025 | 0.144 | Anabolic | 0.144 0.021 DBMET02469 0.138 0.025 DBMET02472 0.12 0.039 DBMET02473 0.129 0.032 DBMET02476 0.129 0.031 DBMET02478 0.142 0.023 DBMET02479 0.136 0.026 DBMET02471 0.14 0.024 DBMET02474 | DBMET02469 | |
| 0.113 | 0.003 | 0.113 | LFA antagonist | 0.044 0.007 DBMET02469 0.113 0.003 DBMET02472 0.035 0.011 DBMET02476 0.052 0.005 DBMET02478 0.026 0.023 DBMET02474 | ||
| 0.109 | 0.005 | 0.109 | Nitric oxide donor | 0.1 0.009 DBMET02469 0.109 0.005 DBMET02472 0.092 0.013 DBMET02473 0.106 0.006 DBMET02475 0.093 0.012 DBMET02476 0.105 0.007 DBMET02478 0.09 0.014 DBMET02479 0.082 0.02 DBMET02470 0.089 0.015 DBMET02471 0.099 0.009 DBMET02474 | ||
| 0.171 | 0.07 | 0.239 | ATPase inhibitor | 0.171 0.07 DBMET02472 0.228 0.02 DBMET02475 0.137 0.127 DBMET02476 0.155 0.093 DBMET02478 0.239 0.017 DBMET02479 0.192 0.045 DBMET02471 | DBMET02479 | |
| 0.118 | 0.018 | 0.141 | Na+ K+ transporting ATPase inhibitor | 0.111 0.023 DBMET02469 0.118 0.018 DBMET02472 0.106 0.026 DBMET02473 0.141 0.008 DBMET02475 0.107 0.025 DBMET02476 0.115 0.02 DBMET02478 0.105 0.028 DBMET02479 0.1 0.032 DBMET02470 0.1 0.032 DBMET02471 0.11 0.023 DBMET02474 | DBMET02475 | |
| 0.169 | 0.074 | 0.178 | Phospholipase C inhibitor | 0.158 0.092 DBMET02469 0.169 0.074 DBMET02472 0.178 0.062 DBMET02473 0.137 0.136 DBMET02476 0.149 0.109 DBMET02478 0.177 0.064 DBMET02479 0.143 0.122 DBMET02471 0.157 0.093 DBMET02474 | DBMET02473 | |
| 0.167 | 0.075 | 0.386 | Growth hormone agonist | 0.187 0.064 DBMET02469 0.167 0.075 DBMET02472 0.386 0.018 DBMET02473 0.144 0.092 DBMET02478 0.159 0.08 DBMET02479 0.154 0.084 DBMET02470 0.163 0.077 DBMET02471 0.166 0.075 DBMET02474 | DBMET02473 | |
| 0.098 | 0.014 | 0.162 | Protein 50S ribosomal subunit inhibitor | 0.06 0.031 DBMET02469 0.098 0.014 DBMET02472 0.098 0.014 DBMET02473 0.162 0.006 DBMET02475 0.13 0.008 DBMET02476 0.116 0.01 DBMET02478 0.07 0.024 DBMET02479 0.065 0.027 DBMET02470 0.085 0.017 DBMET02471 0.105 0.012 DBMET02474 | DBMET02475 | |
| 0.124 | 0.04 | 0.139 | Toll-Like receptor 4 antagonist | 0.136 0.03 DBMET02469 0.124 0.04 DBMET02472 0.093 0.083 DBMET02473 0.139 0.028 DBMET02475 0.099 0.071 DBMET02476 0.115 0.049 DBMET02478 0.134 0.031 DBMET02479 0.092 0.085 DBMET02470 0.11 0.055 DBMET02471 0.098 0.074 DBMET02474 | DBMET02475 | |
| 0.083 | 0.008 | 0.083 | Squalene synthetase inhibitor | 0.052 0.014 DBMET02469 0.083 0.008 DBMET02472 0.043 0.017 DBMET02473 0.076 0.009 DBMET02475 0.063 0.011 DBMET02476 0.073 0.009 DBMET02478 0.03 0.024 DBMET02479 0.037 0.019 DBMET02470 0.056 0.013 DBMET02471 0.05 0.014 DBMET02474 | ||
| 0.152 | 0.079 | 0.301 | Melanin inhibitor | 0.245 0.029 DBMET02469 0.152 0.079 DBMET02472 0.164 0.065 DBMET02473 0.197 0.042 DBMET02475 0.127 0.121 DBMET02476 0.156 0.074 DBMET02478 0.271 0.026 DBMET02479 0.137 0.102 DBMET02470 0.301 0.022 DBMET02471 0.18 0.052 DBMET02474 | DBMET02471 | |
| 0.078 | 0.004 | 0.082 | Prostaglandin E2 agonist | 0.031 0.01 DBMET02469 0.078 0.004 DBMET02472 0.023 0.016 DBMET02473 0.077 0.004 DBMET02478 0.077 0.004 DBMET02479 0.046 0.006 DBMET02471 0.082 0.004 DBMET02474 | DBMET02474 | |
| 0.119 | 0.048 | 0.125 | Protease inhibitor | 0.125 0.044 DBMET02469 0.119 0.048 DBMET02472 0.109 0.057 DBMET02473 0.097 0.068 DBMET02475 0.093 0.071 DBMET02476 0.102 0.064 DBMET02478 0.104 0.062 DBMET02479 0.115 0.051 DBMET02470 0.109 0.058 DBMET02471 0.116 0.05 DBMET02474 | DBMET02469 | |
| 0.07 | 0.004 | 0.165 | ATP citrate lysase inhibitor | 0.133 0.003 DBMET02469 0.07 0.004 DBMET02472 0.071 0.004 DBMET02473 0.036 0.017 DBMET02478 0.165 0.003 DBMET02479 0.131 0.003 DBMET02470 0.085 0.004 DBMET02471 0.08 0.004 DBMET02474 | DBMET02479 | |
| 0.069 | 0.004 | 0.069 | Prostaglandin D2 agonist | 0.056 0.006 DBMET02469 0.069 0.004 DBMET02472 0.06 0.005 DBMET02473 0.05 0.008 DBMET02475 0.052 0.007 DBMET02476 0.068 0.004 DBMET02478 0.069 0.004 DBMET02479 0.05 0.008 DBMET02470 0.054 0.006 DBMET02471 0.068 0.004 DBMET02474 | ||
| 0.065 | 0.003 | 0.079 | Prostaglandin F2 alpha agonist | 0.054 0.004 DBMET02469 0.065 0.003 DBMET02472 0.076 0.003 DBMET02473 0.031 0.008 DBMET02476 0.067 0.003 DBMET02478 0.064 0.003 DBMET02479 0.068 0.003 DBMET02470 0.063 0.003 DBMET02471 0.079 0.002 DBMET02474 | DBMET02474 | |
| 0.059 | 0.004 | 0.061 | Prostacyclin agonist | 0.042 0.005 DBMET02469 0.059 0.004 DBMET02472 0.052 0.004 DBMET02473 0.026 0.007 DBMET02475 0.015 0.011 DBMET02476 0.058 0.004 DBMET02478 0.05 0.004 DBMET02479 0.061 0.004 DBMET02470 0.036 0.005 DBMET02471 0.037 0.005 DBMET02474 | DBMET02470 | |
| 0.076 | 0.022 | 0.114 | Thromboxane antagonist | 0.1 0.011 DBMET02469 0.076 0.022 DBMET02472 0.095 0.013 DBMET02473 0.114 0.008 DBMET02479 0.107 0.009 DBMET02470 0.065 0.029 DBMET02471 0.053 0.038 DBMET02474 | DBMET02479 | |
| 0.058 | 0.005 | 0.072 | Prostaglandin EP2 agonist | 0.05 0.005 DBMET02469 0.058 0.005 DBMET02472 0.058 0.005 DBMET02478 0.072 0.004 DBMET02479 0.031 0.012 DBMET02470 0.056 0.005 DBMET02471 0.046 0.007 DBMET02474 | DBMET02479 | |
| 0.137 | 0.086 | 0.165 | Adenylate cyclase stimulant | 0.156 0.053 DBMET02469 0.137 0.086 DBMET02472 0.133 0.096 DBMET02473 0.128 0.106 DBMET02478 0.157 0.052 DBMET02479 0.165 0.042 DBMET02471 0.125 0.112 DBMET02474 | DBMET02471 | |
| 0.145 | 0.094 | 0.204 | Arachidonic acid antagonist | 0.163 0.073 DBMET02469 0.145 0.094 DBMET02472 0.141 0.099 DBMET02473 0.167 0.068 DBMET02476 0.134 0.108 DBMET02478 0.204 0.03 DBMET02479 0.148 0.091 DBMET02470 0.186 0.048 DBMET02471 0.175 0.059 DBMET02474 | DBMET02479 | |
| 0.062 | 0.013 | 0.069 | Microtubule stabilization | 0.049 0.03 DBMET02469 0.062 0.013 DBMET02472 0.056 0.02 DBMET02473 0.058 0.017 DBMET02475 0.06 0.014 DBMET02476 0.06 0.015 DBMET02478 0.069 0.007 DBMET02470 0.056 0.019 DBMET02471 0.054 0.022 DBMET02474 | DBMET02470 | |
| 0.065 | 0.025 | 0.098 | Thromboxane A2 antagonist | 0.084 0.013 DBMET02469 0.065 0.025 DBMET02472 0.08 0.015 DBMET02473 0.098 0.008 DBMET02479 0.09 0.01 DBMET02470 0.053 0.034 DBMET02471 | DBMET02479 | |
| 0.055 | 0.017 | 0.055 | 5-Alpha-reductase inhibitor | 0.046 0.02 DBMET02469 0.055 0.017 DBMET02472 0.032 0.031 DBMET02473 0.046 0.02 DBMET02478 0.035 0.028 DBMET02474 | ||
| 0.068 | 0.031 | 0.078 | Cathepsin E inhibitor | 0.07 0.029 DBMET02469 0.068 0.031 DBMET02472 0.066 0.033 DBMET02473 0.062 0.037 DBMET02478 0.078 0.024 DBMET02479 0.063 0.036 DBMET02470 0.069 0.03 DBMET02471 0.065 0.034 DBMET02474 | DBMET02479 | |
| 0.072 | 0.036 | 0.074 | Glutamate (mGluR6) antagonist | 0.072 0.036 DBMET02472 0.074 0.033 DBMET02473 0.071 0.037 DBMET02479 | DBMET02473 | |
| 0.175 | 0.144 | 0.31 | Interleukin agonist | 0.234 0.091 DBMET02469 0.175 0.144 DBMET02472 0.31 0.043 DBMET02475 0.192 0.128 DBMET02478 0.259 0.072 DBMET02479 0.171 0.148 DBMET02474 | DBMET02475 | |
| 0.05 | 0.022 | 0.05 | Parathyroid hormone antagonist | 0.05 0.022 DBMET02472 0.046 0.03 DBMET02473 0.044 0.036 DBMET02478 0.047 0.026 DBMET02474 | ||
| 0.06 | 0.036 | 0.069 | Lipocortins synthesis agonist | 0.062 0.031 DBMET02469 0.06 0.036 DBMET02472 0.069 0.022 DBMET02473 0.065 0.027 DBMET02475 0.065 0.027 DBMET02476 0.058 0.041 DBMET02478 0.058 0.039 DBMET02479 0.067 0.024 DBMET02470 0.064 0.028 DBMET02471 0.064 0.028 DBMET02474 | DBMET02473 | |
| 0.169 | 0.146 | 0.219 | DNA damaging | 0.169 0.146 DBMET02472 0.219 0.101 DBMET02475 0.163 0.154 DBMET02479 | DBMET02475 | |
| 0.154 | 0.131 | 0.265 | Neurotrophic factor enhancer | 0.265 0.031 DBMET02469 0.154 0.131 DBMET02472 0.216 0.062 DBMET02476 0.18 0.098 DBMET02478 0.219 0.06 DBMET02479 0.173 0.106 DBMET02471 | DBMET02469 | |
| 0.047 | 0.027 | 0.086 | Macrophage elastase inhibitor | 0.046 0.028 DBMET02469 0.047 0.027 DBMET02472 0.04 0.034 DBMET02473 0.06 0.018 DBMET02478 0.086 0.011 DBMET02479 0.043 0.03 DBMET02471 0.041 0.033 DBMET02474 | DBMET02479 | |
| 0.031 | 0.01 | 0.04 | Toll-Like receptor 4 agonist | 0.031 0.011 DBMET02469 0.031 0.01 DBMET02472 0.031 0.01 DBMET02473 0.04 0.005 DBMET02475 0.029 0.012 DBMET02478 0.03 0.011 DBMET02479 0.026 0.019 DBMET02470 0.032 0.009 DBMET02471 0.029 0.013 DBMET02474 | DBMET02475 | |
| 0.028 | 0.008 | 0.028 | ICAM 1 antagonist | 0.028 0.008 DBMET02472 | ||
| 0.072 | 0.053 | 0.095 | CDC25A inhibitor | 0.095 0.03 DBMET02469 0.072 0.053 DBMET02472 0.072 0.054 DBMET02473 0.068 0.06 DBMET02470 0.08 0.043 DBMET02471 0.079 0.044 DBMET02474 | DBMET02469 | |
| 0.081 | 0.062 | 0.086 | T cell inhibitor | 0.081 0.062 DBMET02472 0.086 0.046 DBMET02476 0.083 0.054 DBMET02478 | DBMET02476 | |
| 0.02 | 0.004 | 0.02 | Thromboxane agonist | 0.012 0.007 DBMET02469 0.02 0.004 DBMET02472 0.015 0.005 DBMET02478 0.013 0.006 DBMET02479 0.011 0.008 DBMET02471 0.013 0.005 DBMET02474 | ||
| 0.053 | 0.041 | 0.053 | Angiotensin-converting enzyme inhibitor | 0.05 0.048 DBMET02469 0.053 0.041 DBMET02472 | ||
| 0.031 | 0.02 | 0.048 | Prostaglandin EP3 antagonist | 0.031 0.02 DBMET02472 0.029 0.022 DBMET02478 0.048 0.01 DBMET02479 0.03 0.021 DBMET02474 | DBMET02479 | |
| 0.019 | 0.008 | 0.02 | Vitamin D receptor agonist | 0.016 0.012 DBMET02469 0.019 0.008 DBMET02472 0.019 0.008 DBMET02473 0.016 0.013 DBMET02478 0.017 0.011 DBMET02479 0.017 0.01 DBMET02471 0.02 0.007 DBMET02474 | DBMET02474 | |
| 0.022 | 0.015 | 0.023 | Vitamin D receptor antagonist | 0.022 0.015 DBMET02472 0.023 0.013 DBMET02473 0.021 0.019 DBMET02475 0.022 0.015 DBMET02476 0.021 0.018 DBMET02478 0.023 0.013 DBMET02474 | DBMET02474 | |
| 0.024 | 0.017 | 0.066 | Protein 30S ribosomal subunit inhibitor | 0.023 0.018 DBMET02469 0.024 0.017 DBMET02472 0.066 0.005 DBMET02475 0.032 0.012 DBMET02476 0.023 0.018 DBMET02478 0.024 0.017 DBMET02471 0.027 0.014 DBMET02474 | DBMET02475 | |
| 0.014 | 0.008 | 0.014 | Integrin beta2 antagonist | 0.014 0.008 DBMET02472 | ||
| 0.015 | 0.009 | 0.027 | Antibiotic Macrolide-like | 0.015 0.009 DBMET02472 0.017 0.008 DBMET02473 0.027 0.005 DBMET02475 0.025 0.005 DBMET02476 0.018 0.007 DBMET02478 0.013 0.011 DBMET02471 0.019 0.007 DBMET02474 | DBMET02475 | |
| 0.045 | 0.04 | 0.066 | Glucose-6-phosphate isomerase inhibitor | 0.045 0.04 DBMET02472 0.051 0.028 DBMET02473 0.046 0.037 DBMET02475 0.066 0.014 DBMET02479 0.048 0.033 DBMET02471 0.048 0.033 DBMET02474 | DBMET02479 | |
| 0.015 | 0.011 | 0.015 | Thromboxane A2 agonist | 0.015 0.011 DBMET02472 0.015 0.012 DBMET02479 | ||
| 0.066 | 0.063 | 0.076 | Glycine receptor agonist | 0.069 0.058 DBMET02469 0.066 0.063 DBMET02472 0.076 0.044 DBMET02479 | DBMET02479 | |
| 0.033 | 0.033 | 0.054 | Glutamate (mGluR8) antagonist | 0.054 0.007 DBMET02473 0.044 0.013 DBMET02479 0.045 0.012 DBMET02470 | DBMET02473 | |
| 0.038 | 0.038 | 0.039 | HIV-1 protease inhibitor | 0.039 0.037 DBMET02469 0.039 0.037 DBMET02474 | DBMET02474 | |
| 0.014 | 0.015 | 0.015 | Antibiotic Tetracycline-like | 0.015 0.013 DBMET02476 0.015 0.013 DBMET02474 | DBMET02474 | |
| 0.058 | 0.059 | 0.135 | Phosphofructokinase-1 inhibitor | 0.059 0.057 DBMET02473 0.103 0.031 DBMET02475 0.135 0.021 DBMET02479 | DBMET02479 | |
| 0.015 | 0.017 | 0.02 | Telomerase stimulant | 0.02 0.007 DBMET02475 | DBMET02475 | |
| 0.032 | 0.034 | 0.068 | Antibiotic Aminoglycoside-like | 0.034 0.028 DBMET02473 0.068 0.006 DBMET02475 0.037 0.024 DBMET02476 0.034 0.028 DBMET02474 | DBMET02475 | |
| 0.026 | 0.029 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.024 DBMET02469 0.03 0.017 DBMET02475 0.028 0.022 DBMET02471 | DBMET02475 | |
| 0.094 | 0.098 | 0.128 | Electron transport complex I inhibitor | 0.098 0.086 DBMET02469 0.107 0.067 DBMET02479 0.128 0.037 DBMET02470 0.098 0.087 DBMET02471 0.096 0.093 DBMET02474 | DBMET02470 | |
| 0.083 | 0.092 | 0.216 | Expectorant | 0.092 0.078 DBMET02469 0.101 0.068 DBMET02473 0.216 0.017 DBMET02475 0.133 0.043 DBMET02479 0.098 0.071 DBMET02471 | DBMET02475 | |
| 0.018 | 0.032 | 0.029 | RNA-directed RNA polymerase stimulant | 0.029 0.021 DBMET02469 | DBMET02469 | |
| 0.087 | 0.102 | 0.163 | DNA polymerase I inhibitor | 0.128 0.062 DBMET02469 0.104 0.082 DBMET02475 0.127 0.063 DBMET02479 0.122 0.067 DBMET02471 0.163 0.042 DBMET02474 | DBMET02474 | |
| 0.047 | 0.069 | 0.059 | Adenine nucleotide translocase inhibitor | 0.059 0.03 DBMET02475 0.058 0.033 DBMET02479 | DBMET02475 | |
| 0.047 | 0.074 | 0.095 | Leukotriene antagonist | 0.095 0.024 DBMET02479 0.07 0.04 DBMET02474 | DBMET02479 | |
| 0.015 | 0.042 | 0.024 | Leukotriene B4 receptor 1 antagonist | 0.024 0.023 DBMET02479 | DBMET02479 | |
| 0.041 | 0.071 | 0.063 | Neuraminidase inhibitor | 0.063 0.04 DBMET02475 | DBMET02475 | |
| 0.025 | 0.061 | 0.036 | Tubulin agonist | 0.036 0.021 DBMET02470 | DBMET02470 | |
| 0.049 | 0.088 | 0.065 | Neuraminidase (influenza) inhibitor | 0.065 0.042 DBMET02475 | DBMET02475 | |
| 0.079 | 0.117 | 0.119 | Mucolytic | 0.119 0.055 DBMET02479 | DBMET02479 | |
| 0.053 | 0.094 | 0.102 | Glutamate dehydrogenase inhibitor | 0.102 0.03 DBMET02479 | DBMET02479 | |
| 0.123 | 0.165 | 0.131 | Ca2+-transporting ATPase inhibitor | 0.131 0.114 DBMET02479 | DBMET02479 | |
| 0.131 | 0.175 | 0.34 | Free radical scavenger | 0.149 0.146 DBMET02469 0.34 0.041 DBMET02475 0.214 0.087 DBMET02479 0.156 0.138 DBMET02471 | DBMET02475 | |
| 0.124 | 0.169 | 0.219 | Succinate dehydrogenase inhibitor | 0.146 0.12 DBMET02469 0.219 0.036 DBMET02479 | DBMET02479 | |
| 0.098 | 0.143 | 0.115 | Neurotrophic factor | 0.115 0.104 DBMET02476 | DBMET02476 | |
| 0.038 | 0.085 | 0.057 | Androgen agonist | 0.057 0.045 DBMET02476 | DBMET02476 | |
| 0.066 | 0.116 | 0.108 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.081 0.079 DBMET02478 0.108 0.047 DBMET02479 | DBMET02479 | |
| 0.096 | 0.146 | 0.197 | Cell wall synthesis inhibitor | 0.197 0.031 DBMET02475 | DBMET02475 | |
| 0.021 | 0.072 | 0.172 | Estrogen agonist | 0.172 0.01 DBMET02479 | DBMET02479 | |
| 0.131 | 0.185 | 0.3 | Tumour necrosis factor alpha release inhibitor | 0.186 0.121 DBMET02473 0.3 0.053 DBMET02475 0.162 0.143 DBMET02479 | DBMET02475 | |
| 0.004 | 0.058 | 0.019 | Prostaglandin EP4 agonist | 0.019 0.009 DBMET02479 | DBMET02479 | |
| 0.034 | 0.094 | 0.075 | Leukotriene B4 antagonist | 0.075 0.017 DBMET02479 | DBMET02479 | |
| 0.011 | 0.071 | 0.02 | Leukotriene B4 receptor 2 antagonist | 0.02 0.018 DBMET02479 | DBMET02479 | |
| 0.015 | 0.076 | 0.023 | Vanilloid 2 agonist | 0.023 0.022 DBMET02475 | DBMET02475 | |
| 0.025 | 0.091 | 0.047 | Prostaglandin antagonist | 0.047 0.042 DBMET02479 | DBMET02479 | |
| 0.11 | 0.178 | 0.149 | Antimitotic | 0.149 0.122 DBMET02470 | DBMET02470 | |
| 0.034 | 0.106 | 0.146 | Peroxisome proliferator-activated receptor gamma agonist | 0.146 0.014 DBMET02479 | DBMET02479 | |
| 0.033 | 0.106 | 0.061 | Glucose-6-phosphate translocase inhibitor | 0.061 0.022 DBMET02475 0.053 0.033 DBMET02471 | DBMET02475 | |
| 0.011 | 0.084 | 0.027 | Prostaglandin EP4 antagonist | 0.027 0.017 DBMET02479 | DBMET02479 | |
| 0.043 | 0.116 | 0.091 | Aminopeptidase I inhibitor | 0.091 0.033 DBMET02479 | DBMET02479 | |
| 0.014 | 0.089 | 0.032 | Fumarate hydratase inhibitor | 0.032 0.026 DBMET02479 | DBMET02479 | |
| 0.121 | 0.197 | 0.185 | Spasmolytic | 0.159 0.156 DBMET02475 0.158 0.157 DBMET02479 0.185 0.133 DBMET02474 | DBMET02474 | |
| 0.061 | 0.139 | 0.11 | Transcription factor NF kappa B stimulant | 0.11 0.031 DBMET02475 | DBMET02475 | |
| 0.064 | 0.145 | 0.085 | Vanilloid agonist | 0.085 0.057 DBMET02479 | DBMET02479 | |
| 0.03 | 0.113 | 0.079 | Carbamoyl phosphate synthetase inhibitor | 0.079 0.029 DBMET02479 | DBMET02479 | |
| 0.076 | 0.161 | 0.19 | Toll-Like receptor 2 antagonist | 0.19 0.029 DBMET02479 | DBMET02479 | |
| 0.028 | 0.117 | 0.262 | Selectin antagonist | 0.262 0.008 DBMET02475 | DBMET02475 | |
| 0.071 | 0.161 | 0.145 | Alpha-N-acetylglucosaminidase inhibitor | 0.145 0.058 DBMET02479 | DBMET02479 | |
| 0.138 | 0.231 | 0.234 | DNA synthesis inhibitor | 0.206 0.115 DBMET02473 0.234 0.079 DBMET02475 0.193 0.134 DBMET02479 | DBMET02475 | |
| 0.068 | 0.168 | 0.096 | Adenylate kinase inhibitor | 0.096 0.074 DBMET02479 | DBMET02479 | |
| 0.027 | 0.13 | 0.075 | Aconitate hydratase inhibitor | 0.075 0.016 DBMET02479 | DBMET02479 | |
| 0.004 | 0.111 | 0.049 | Estrogen receptor alpha agonist | 0.049 0.018 DBMET02479 | DBMET02479 | |
| 0.07 | 0.177 | 0.18 | TRPA1 agonist | 0.18 0.015 DBMET02479 | DBMET02479 | |
| 0.045 | 0.157 | 0.11 | Aminopeptidase B inhibitor | 0.11 0.058 DBMET02479 | DBMET02479 | |
| 0.086 | 0.198 | 0.129 | Farnesoid X receptor antagonist | 0.129 0.085 DBMET02479 | DBMET02479 | |
| 0.096 | 0.209 | 0.296 | Interleukin 6 antagonist | 0.131 0.124 DBMET02469 0.232 0.027 DBMET02473 0.153 0.084 DBMET02475 0.141 0.103 DBMET02479 0.296 0.015 DBMET02470 | DBMET02470 | |
| 0.069 | 0.182 | 0.151 | Photosensitizer | 0.151 0.03 DBMET02479 | DBMET02479 | |
| 0.099 | 0.216 | 0.209 | Non-steroidal antiinflammatory agent | 0.195 0.075 DBMET02475 0.209 0.064 DBMET02479 | DBMET02479 | |
| 0.056 | 0.173 | 0.116 | Bile acid receptor antagonist | 0.116 0.023 DBMET02479 | DBMET02479 | |
| 0.087 | 0.207 | 0.133 | Vanilloid 1 agonist | 0.133 0.061 DBMET02479 | DBMET02479 | |
| 0.028 | 0.158 | 0.08 | Catalase inhibitor | 0.08 0.048 DBMET02479 | DBMET02479 | |
| 0.059 | 0.195 | 0.079 | Hematopoietic | 0.079 0.076 DBMET02479 | DBMET02479 | |
| 0.012 | 0.155 | 0.093 | Peroxisome proliferator-activated receptor alpha agonist | 0.093 0.014 DBMET02479 | DBMET02479 | |
| 0.02 | 0.164 | 0.093 | HIV-1 integrase (Strand Transfer) inhibitor | 0.093 0.025 DBMET02474 | DBMET02474 | |
| 0.028 | 0.179 | 0.053 | Sphingosine 1-phosphate receptor 5 agonist | 0.053 0.039 DBMET02479 | DBMET02479 | |
| 0.019 | 0.171 | 0.104 | Alcohol oxidase inhibitor | 0.104 0.017 DBMET02479 | DBMET02479 | |
| 0.037 | 0.192 | 0.104 | Protein-tyrosine phosphatase 1B inhibitor | 0.104 0.074 DBMET02479 | DBMET02479 | |
| 0.079 | 0.239 | 0.272 | Platelet adhesion inhibitor | 0.272 0.042 DBMET02475 | DBMET02475 | |
| 0.022 | 0.188 | 0.059 | HIV-1 integrase (3'-Processing) inhibitor | 0.059 0.048 DBMET02474 | DBMET02474 | |
| 0.058 | 0.229 | 0.162 | Cyclooxygenase 3 inhibitor | 0.162 0.039 DBMET02475 0.108 0.092 DBMET02479 | DBMET02475 | |
| 0.103 | 0.277 | 0.213 | Catenin beta inhibitor | 0.213 0.024 DBMET02479 | DBMET02479 | |
| 0.045 | 0.223 | 0.11 | Triose-phosphate isomerase inhibitor | 0.11 0.039 DBMET02479 | DBMET02479 | |
| 0.051 | 0.233 | 0.203 | Thrombolytic | 0.203 0.05 DBMET02475 | DBMET02475 | |
| 0.136 | 0.318 | 0.455 | Histamine release inhibitor | 0.322 0.113 DBMET02475 0.455 0.048 DBMET02479 | DBMET02479 | |
| 0.013 | 0.196 | 0.036 | Glutamate (mGluR3) antagonist | 0.036 0.027 DBMET02479 | DBMET02479 | |
| 0.037 | 0.231 | 0.069 | Keratolytic | 0.069 0.066 DBMET02479 | DBMET02479 | |
| 0.055 | 0.25 | 0.15 | Estrogen antagonist | 0.15 0.023 DBMET02479 | DBMET02479 | |
| 0.06 | 0.258 | 0.101 | Folate antagonist | 0.101 0.063 DBMET02479 | DBMET02479 | |
| 0.129 | 0.327 | 0.29 | Tyrosine 3 hydroxylase inhibitor | 0.29 0.038 DBMET02479 | DBMET02479 | |
| 0.045 | 0.254 | 0.146 | Lipid peroxidase inhibitor | 0.146 0.071 DBMET02475 0.138 0.077 DBMET02479 | DBMET02475 | |
| 0.02 | 0.236 | 0.101 | Leukotriene synthesis inhibitor | 0.101 0.026 DBMET02479 | DBMET02479 | |
| 0.035 | 0.255 | 0.1 | Prolactin inhibitor | 0.1 0.055 DBMET02479 | DBMET02479 | |
| 0.051 | 0.273 | 0.078 | Estrogen-related receptor beta agonist | 0.078 0.076 DBMET02479 | DBMET02479 | |
| 0.031 | 0.26 | 0.061 | Leukotriene C antagonist | 0.061 0.027 DBMET02479 | DBMET02479 | |
| 0.043 | 0.283 | 0.23 | Psychostimulant | 0.23 0.066 DBMET02479 | DBMET02479 | |
| 0.02 | 0.263 | 0.039 | Leukotriene C4 antagonist | 0.039 0.028 DBMET02479 | DBMET02479 | |
| 0.066 | 0.315 | 0.142 | Platelet aggregation inhibitor | 0.142 0.139 DBMET02479 | DBMET02479 | |
| 0.04 | 0.289 | 0.19 | Amylase inhibitor | 0.102 0.095 DBMET02475 0.19 0.048 DBMET02479 | DBMET02479 | |
| 0.049 | 0.299 | 0.134 | Cell adhesion inhibitor | 0.134 0.056 DBMET02475 | DBMET02475 | |
| 0.018 | 0.275 | 0.108 | Monophenol monooxygenase inhibitor | 0.097 0.079 DBMET02475 0.108 0.07 DBMET02479 | DBMET02479 | |
| 0.018 | 0.276 | 0.133 | Glutamate decarboxylase inhibitor | 0.133 0.017 DBMET02479 | DBMET02479 | |
| 0.04 | 0.302 | 0.119 | Protein-tyrosine phosphatase inhibitor | 0.119 0.115 DBMET02479 | DBMET02479 | |
| 0.05 | 0.319 | 0.163 | Diuretic | 0.163 0.067 DBMET02475 | DBMET02475 | |
| 0.032 | 0.302 | 0.141 | GABA C receptor agonist | 0.141 0.038 DBMET02479 | DBMET02479 | |
| 0.097 | 0.367 | 0.21 | Nootropic | 0.21 0.146 DBMET02476 | DBMET02476 | |
| 0.046 | 0.325 | 0.25 | Phospholipase A2 inhibitor | 0.25 0.023 DBMET02479 | DBMET02479 | |
| 0.022 | 0.313 | 0.08 | GABA aminotransferase inhibitor | 0.08 0.047 DBMET02479 | DBMET02479 | |
| 0.022 | 0.323 | 0.174 | Alcohol dehydrogenase inhibitor | 0.174 0.015 DBMET02479 | DBMET02479 | |
| 0.073 | 0.38 | 0.127 | Papain-like protease (SARS coronavirus) inhibitor | 0.127 0.066 DBMET02479 | DBMET02479 | |
| 0.04 | 0.359 | 0.141 | Anesthetic general | 0.141 0.123 DBMET02471 | DBMET02471 | |
| 0.116 | 0.448 | 0.242 | 5 Hydroxytryptamine uptake stimulant | 0.242 0.089 DBMET02479 | DBMET02479 | |
| 0.053 | 0.39 | 0.512 | Insulin secretagoues | 0.131 0.096 DBMET02473 0.129 0.098 DBMET02475 0.476 0.005 DBMET02476 0.512 0.005 DBMET02478 0.121 0.109 DBMET02471 | DBMET02478 | |
| 0.123 | 0.468 | 0.347 | 5 Hydroxytryptamine release inhibitor | 0.347 0.118 DBMET02479 | DBMET02479 | |
| 0.123 | 0.48 | 0.415 | Caspase 9 stimulant | 0.415 0.102 DBMET02479 | DBMET02479 | |
| 0.026 | 0.415 | 0.083 | HIV-1 integrase (Overall Integration) inhibitor | 0.083 0.074 DBMET02479 | DBMET02479 | |
| 0.073 | 0.467 | 0.494 | Immunomodulator | 0.303 0.081 DBMET02475 0.494 0.024 DBMET02476 | DBMET02476 | |
| 0.026 | 0.426 | 0.091 | Estrogen receptor alpha antagonist | 0.091 0.034 DBMET02479 | DBMET02479 | |
| 0.02 | 0.422 | 0.175 | Cystathionine beta-synthase inhibitor | 0.175 0.031 DBMET02479 | DBMET02479 | |
| 0.018 | 0.429 | 0.073 | Peroxisome proliferator-activated receptor gamma antagonist | 0.073 0.045 DBMET02479 | DBMET02479 | |
| 0.039 | 0.45 | 0.343 | Aldehyde oxidase inhibitor | 0.343 0.057 DBMET02479 | DBMET02479 | |
| 0.011 | 0.422 | 0.125 | Phenylalanine 4-hydroxylase inhibitor | 0.125 0.017 DBMET02479 | DBMET02479 | |
| 0.009 | 0.421 | 0.106 | Plasminogen activator inhibitor antagonist | 0.106 0.009 DBMET02479 | DBMET02479 | |
| 0.003 | 0.427 | 0.068 | Sigma 1 receptor antagonist | 0.068 0.008 DBMET02479 | DBMET02479 | |
| 0.067 | 0.505 | 0.177 | RNA-directed DNA polymerase inhibitor | 0.165 0.163 DBMET02476 0.177 0.138 DBMET02479 | DBMET02479 | |
| 0.018 | 0.46 | 0.126 | GABA C receptor antagonist | 0.126 0.046 DBMET02479 | DBMET02479 | |
| 0.017 | 0.501 | 0.125 | Estrogen receptor beta antagonist | 0.125 0.027 DBMET02479 | DBMET02479 | |
| 0.008 | 0.496 | 0.068 | Porphobilinogen synthase inhibitor | 0.068 0.058 DBMET02479 | DBMET02479 | |
| 0.01 | 0.504 | 0.067 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.067 0.024 DBMET02479 | DBMET02479 | |
| 0.018 | 0.518 | 0.076 | GABA B receptor agonist | 0.076 0.052 DBMET02479 | DBMET02479 | |
| 0.03 | 0.53 | 0.265 | Peroxidase inhibitor | 0.265 0.044 DBMET02479 | DBMET02479 | |
| 0.043 | 0.545 | 0.145 | Sigma receptor agonist | 0.145 0.088 DBMET02479 | DBMET02479 | |
| 0.004 | 0.532 | 0.059 | Sigma receptor antagonist | 0.059 0.028 DBMET02479 | DBMET02479 | |
| 0.022 | 0.569 | 0.117 | DOPA decarboxylase inhibitor | 0.117 0.049 DBMET02479 | DBMET02479 | |
| 0.073 | 0.624 | 0.166 | Nitric-oxide synthase stimulant | 0.166 0.162 DBMET02479 | DBMET02479 | |
| 0.007 | 0.561 | 0.063 | Histidine decarboxylase inhibitor | 0.063 0.059 DBMET02479 | DBMET02479 | |
| 0.013 | 0.574 | 0.088 | Creatine kinase inhibitor | 0.088 0.074 DBMET02479 | DBMET02479 | |
| 0.092 | 0.665 | 0.416 | Calcium channel L-type activator | 0.416 0.071 DBMET02479 | DBMET02479 | |
| 0.02 | 0.597 | 0.102 | Aldehyde dehydrogenase inhibitor | 0.102 0.095 DBMET02479 | DBMET02479 | |
| 0.043 | 0.627 | 0.145 | Neurotensin receptor agonist | 0.145 0.114 DBMET02479 | DBMET02479 | |
| 0.043 | 0.643 | 0.25 | Insulysin inhibitor | 0.25 0.097 DBMET02479 | DBMET02479 | |
| 0.007 | 0.777 | 0.044 | DNA polymerase III inhibitor | 0.044 0.004 DBMET02470 | DBMET02470 | |
| 0.005 | 0.793 | 0.185 | Lipoxygenase inhibitor | 0.185 0.157 DBMET02479 | DBMET02479 | |
| 0.005 | 0.836 | 0.063 | Plasminogen activator inhibitor | 0.063 0.037 DBMET02479 | DBMET02479 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |